DRUG News - Blockchain.News

DEEPSEEK

Lilly Unveils Groundbreaking AI Factory for Drug Discovery with NVIDIA's DGX SuperPOD
deepseek

Lilly Unveils Groundbreaking AI Factory for Drug Discovery with NVIDIA's DGX SuperPOD

Lilly has launched the largest AI factory in the pharmaceutical sector, leveraging NVIDIA's DGX SuperPOD to revolutionize drug discovery and personalized medicine.

NVIDIA Unveils Biomedical AI-Q Blueprint for Enhanced Drug Discovery
deepseek

NVIDIA Unveils Biomedical AI-Q Blueprint for Enhanced Drug Discovery

NVIDIA introduces the Biomedical AI-Q Research Agent Blueprint, streamlining drug discovery by expediting literature review and hypothesis generation through AI-driven solutions.

NVIDIA and Novo Nordisk Collaborate to Enhance Drug Discovery with AI
deepseek

NVIDIA and Novo Nordisk Collaborate to Enhance Drug Discovery with AI

NVIDIA partners with Novo Nordisk and DCAI to leverage AI technology in advancing drug discovery, utilizing the Gefion supercomputer for innovative pharmaceutical research.

AI and Organoids Revolutionize Brain Disease Research
deepseek

AI and Organoids Revolutionize Brain Disease Research

BrainStorm Therapeutics leverages AI and organoids to advance drug discovery for brain diseases, aiming to reduce clinical trial failures and accelerate treatment development.

Cryptocurrency's Role in Fentanyl Trafficking and Countermeasures
deepseek

Cryptocurrency's Role in Fentanyl Trafficking and Countermeasures

Cryptocurrency is increasingly used in fentanyl trafficking, with blockchain intelligence offering critical tools to combat this global issue, according to Chainalysis.

Protai Leverages NVIDIA NIM and AlphaFold for Enhanced Protein Structure Prediction
deepseek

Protai Leverages NVIDIA NIM and AlphaFold for Enhanced Protein Structure Prediction

Protai advances drug discovery by integrating NVIDIA NIM with AlphaFold and proteomics, optimizing protein structure predictions for precision medicine.

GenMol: A New Frontier in Molecular Generation for Drug Discovery
deepseek

GenMol: A New Frontier in Molecular Generation for Drug Discovery

Explore GenMol, a generalist foundation model for molecular generation, and its advantages over SAFE-GPT in the realm of AI-driven drug discovery.

NVIDIA Introduces BioNeMo Blueprint to Revolutionize Protein Binder Design
deepseek

NVIDIA Introduces BioNeMo Blueprint to Revolutionize Protein Binder Design

NVIDIA unveils the BioNeMo Blueprint, a new AI-powered approach to accelerate protein binder design in drug discovery, leveraging GPU-accelerated microservices.

Mitsui & Co's Xeureka Utilizes NVIDIA AI for Secure Drug Discovery
deepseek

Mitsui & Co's Xeureka Utilizes NVIDIA AI for Secure Drug Discovery

Xeureka, a subsidiary of Mitsui & Co, leverages NVIDIA's AI platform to safely share healthcare data, enhancing drug discovery efforts through advanced confidential computing.

AI-Driven Drug Discovery Revolutionizes Treatment Development
deepseek

AI-Driven Drug Discovery Revolutionizes Treatment Development

AI's integration into drug discovery is transforming the development of treatments, reducing time and cost significantly, according to NVIDIA's blog.

Trending topics